Skip to main content
    • Aa
    • Aa

Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia

  • J. L. Waddington (a1), H. A. Youssef (a1) and A. Kinsella (a1)

Current clinical correlates of duration of initially untreated psychotic symptoms were investigated in a cross-sectional analysis followed by a 10-year prospective study among 88 inpatients with a long-standing schizophrenic illness, many of whom had experienced prolonged periods of untreated psychosis due to illness onset and hospital admission in the pre-neuroleptic era. After controlling for the effects of age, and duration and continuity of subsequent neuroleptic treatment, the primary clinical correlate of duration of initially untreated psychosis was muteness. Over the subsequent 10-year-period, no new cases of muteness emerged and some existing cases of muteness partially resolved, though the speech that emerged remained very sparse and revealed generally gross cognitive debility. The pathophysiology underlying active, unchecked psychosis may also constitute an active morbid process that is associated with the further progression of severe negative symptoms and cognitive dysfunction in the long-term.

Corresponding author
1Address for correspondence: Professor John L. Waddington, Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, St Stephen's Green, Dublin 2, Ireland.
Hide All
Abrahamson D. (1993). Institutionalisation and the long-term course schizophrenia. British Journal of Psychiatry 162, 533538.
Altshuler L. L., Cummings J. L. & Mills M. J. (1986). Mutism: review, differential diagnosis, and report of 22 cases. American Journal of Psychiatry 143, 14091414.
Andreasen N. C. (1982). Negative symptoms in schizophrenia. Archives of General Psychiatry 39, 784788.
Andreasen N. C. & Flaum M. (1991). Schizophrenia: the characteristic symptoms. Schizophrenia Bulletin 17, 2749.
Andreasen N. C., Flaum M., Swayze V. W., Tyrrell G. & Arndt S. (1990). Positive and negative symptoms in schizophrenia: a critical reappraisal. Archives of General Psychiatry 47, 615621.
Baldessarini R. J. (1985). Chemotherapy in Psychiatry. Harvard University Press: Cambridge.
Benes F. M. (1993). Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophrenia Bulletin 19, 537549.
Bleuler M. (1978). The Schizophrenic Disorders: Long-term Patient and Family Studies. (Translated by Clemens S. M..) Yale University Press: New Haven.
Bogerts B. (1993). Recent advances in the neuropathology of schizophrenia. Schizophrenia Bulletin 19, 431445.
Breier A., Schreiber J. L., Dyer J. & Pickar D. (1991). National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Archives of General Psychiatry 48, 239246.
Carone B. J., Harrow M. & Westermeyer J. F. (1991). Posthospital course and outcome in schizophrenia. Archives of General Psychiatry 48, 247253.
Ciompi L. (1980). The natural history of schizophrenia in the long term. British Journal of Psychiatry 136, 413420.
Crow T. J. & Stevens M. (1978). Age disorientation in chronic schizophrenia: the nature of the cognitive deficit. British Journal of Psychiatry 133, 137142.
Crow T. J., Macmillan J. F., Johnson A. L. & Johnstone E. C. (1986). A randomised controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 148, 120127.
Davis J. M. (1976). Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 33, 858861.
Davis J. M. & Andriukaitis S. (1986). The natural course of schizophrenia and effective maintenance drug treatment. Journal Clinical Psychopharmacology 6 (suppl.), 2S10S.
Degreef G., Ashtari M., Bogerts B., Bilder R. M., Jody D. N., Alvir J., Ma J. & Lieberman J. A. (1992). Volumes of ventricular system subdivisions measured from magnetic resonance images in first episode schizophrenic patients. Archives of General Psychiatry 49, 531537.
DeLisi L. E. & Lieberman J. A. (1991). Longitudinal perspectives on the pathophysiology of schizophrenia: examining the neurodevelopmental versus neurodegenerative hypotheses. Schizophrenia Research 5, 183210.
DeLisi L. E., Stritzke P., Riordan H., Holan V., Boccio A., Kusher M., McClelland J., Van Exl O. & Anand A. (1992). The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biological Psychiatry 31, 241254.
Feighner J. P., Robins E., Guze S. B., Woodruff R. A. & Winokur G. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26, 5763.
Fenton W. S. & McGlashan T. H. (1991). Natural history schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry 48, 969977.
Fenton W. S. & McGlashan T. H. (1992). Testing systems for assessment of negative symptoms in schizophrenia. Archives of General Psychiatry 49, 179184.
Fostl H., Besthorn C., Geiger-Kabisch C., Sattel H. & Schreiter-Gasser U. (1993). Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerised tomography findings. Acta Psychiatrica Scandinavica 87, 395399.
Harding C. M., Brooks G. W., Ashikaga T., Strauss J. S. & Breier A. (1987). The Vermont longitudinal study of persons with severe mental illness, II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. American Journal of Psychiatry 144, 727735.
Harding C. M., Zubin J. & Strauss J. S. (1992). Chronicity in schizophrenia: revisited. British Journal of Psychiatry 161 (suppl. 18). 2737.
Hare E. H. (1974). The changing content of psychiatric illness. Journal of Psychosomatic Research 18, 283289.
Harrison G. & Mason P. (1993). Schizophrenia – falling incidence and better outcome? British Journal of Psychiatry 163, 535541.
Iager A. C., Kirch D. G. & Wyatt R. J. (1985). A negative symptom rating scale. Psychiatry Research 16, 2736.
Johnson J. (1993). Catatonia: the tension insanity. British Journal of Psychiatry 162, 733738.
Kane J. M. & Lieberman J. A. (1987). Maintenance pharmacotherapy in schizophrenia. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer H. Y.), pp. 11031109. Raven Press: New York.
Kelley M. E., Gilbertson M., Mouton A. & van Kammen D. P. (1992). Deterioration in premorbid functioning in schizophrenia: a developmental model of negative symptoms in drug-free patients. American Journal of Psychiatry 149, 15431548.
Kirkpatrick B., Buchanan R. W., McKenney P. D., Alphs L. D. & Carpenter W. T. (1989). The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Research 30, 119123.
Kleist K. (1960). Schizophrenic symptoms and cerebral pathology. Journal of Mental Science 106, 246253.
Kraepelin E. (1919). Dementia Praecox and Paraphrenia. (Translated by Barclay R. M..) Livingstone: Edinburgh.
Krawiecka M., Goldberg D. & Vaughan M. (1977). A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica 55, 299308.
Leonhard K. (1961). The cycloid psychoses. Journal of Mental Science 107, 633648.
Loebel M. D., Lieberman J. A., Alvir J. M. J., Mayerhoff D. I., Geisler S. H. & Szymanski S. R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. American Journal Psychiatry 149, 11831188.
McEvoy J. P., Schooler N. R. & Wilson W. H. (1991). Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacology Bulletin 27, 97101.
McGlashan T. H. & Fenton W. S. (1992). The positive–negative distinction in schizophrenia: review of natural history validators. Archives of General Psychiatry 49, 6372.
McGlashan T. H. & Fenton W. S. (1993). Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin 19, 7184.
Mahendra B. (1981). Where have all the catatonics gone? Psychological Medicine 11, 669671.
Manschreck T. C., Maher B. A., Rucklos M. E. & Vereen D. R. (1982). Disturbed voluntary motor activity in schizophrenic disorder. Psychological Medicine 12, 7384.
Morrison J. R. (1974). Changes in subtype diagnosis of schizophrenia. American Journal of Psychiatry 131, 674677.
Mortimer A. M., Lund C. E. & McKenna P. J. (1990). The positive: negative dichotomy in schizophrenia. British Journal of Psychiatry 157, 4149.
Murray R. M. & Lewis S. W. (1987). Is schizophrenia a ncurodevelopmental disorder? British Medical Journal 295, 681682.
O'Callaghan E., Buckley P., Redmond O., Stack J., Ennis J. T., Larkin C. & Waddington J. L. (1992). Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis. Journal of the Royal Society of Medicine 85, 227231.
Qureshi K. N. & Hodkinson H. M. (1974). Evaluation of a ten-question mental test in the institutionalised elderly. Age and Ageing 3, 152157.
Raskìn A., Pelchat R., Sood R., Alphs L. D. & Levine J. (1993). Negative symptom assessment of chronic schizophrenia patients. Schizophrenia Bulletin 19, 627635.
Tune L. E, Wong D. F., Pearlson G., Strauss M., Young T., Shaya E. K., Dannals R. F., Wilson A. A., Ravert H. T., Sapp J., Cooper T., Chase G. A. & Wagner H. N. (1993). Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone. Psychiatry Research 49, 219237.
Waddington J. L. (1993 a). Schizophrenia: developmental neuroscience and pathobiology. Lancet 341, 531536.
Waddington J. L. (1993 b). Neurodynamics of abnormalities in cerebral metabolism and structure in schizophrenia. Schizophrenia Bulletin 19, 5569.
Waddington J. L. (1995). The clinical psychopharmacology of antipsychotic drugs in schizophrenia. In Schizophrenia (ed. Hirsch S. R. and Weinberger D. R.), pp. 341357. Blackwell: Oxford.
Waddington J. L. & Youssef H. A. (1986 a). An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. American Journal of Psychiatry 143, 11621165.
Waddington J. L. & Youssef H. A. (1986 b). Late-onset involuntary movements in chronic schizophrenia: relationship of tardive dyskinesia to intellectual impairment and negative symptoms. British Journal of Psychiatry 149, 616620.
Waddington J. L., Youssef H. A., Dolphin C. & Kinsella A. (1987). Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Archives of General Psychiatry 44, 907912.
Weinberger D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 44, 660669.
Wing J. K. & Brown G. W. (1970). Institutionalism and Schizophrenia. Cambridge University Press: Cambridge.
Wyatt R. J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophrenia Bulletin 17, 325351.
Zubin J., Magaziner J. & Steinhauer S. R. (1983). The metamorphosis of schizophrenia: from chronicity to vulnerability. Psychological Medicine 13, 551571.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 6 *
Loading metrics...

Abstract views

Total abstract views: 119 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.